Nature Medicine
- 12, 1181 - 1184 (2006)
Published online: 1 October 2006; | doi:10.1038/nm1487
Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implicationsIngo Roeder, Matthias Horn, Ingmar Glauche, Andreas Hochhaus, Martin C Mueller & Markus Loeffler Supplementary Fig. 1 (pdf 136K)
Simulation of CML genesis. Supplementary Fig. 2 (pdf 232K)
Transition characteristics. Supplementary Fig. 3 (pdf 588K)
Individual subject data. Supplementary Fig. 4 (pdf 192K)
Model prediction for combination of imatinib with cytotoxic treatment. Supplementary Fig. 5 (pdf 196K)
Computer simulation of prolonged imatinib administration. Supplementary Table 1 (pdf 60K)
Model parameters for normal and leukemic cells. Supplementary Table 2 (pdf 52K)
Model parameters for treatment simulation. Supplementary Note (pdf 208K)
| 
